Dashboard
Manage Tickers

ARMP


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

armata-pharmaceuticals--appoints-david-house-as-svp-of-finance-and-principal-financial-officer
Armata Pharmaceuticals Appoints David Hou...
08/15/2024 20:46:39

Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a biotechnology company focused on the de...

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
08/15/2024 10:18:54

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-q2-2024-gaap-eps-025-beats-044-estimate
Armata Pharmaceuticals Q2 2024 GAAP EPS $(...
08/13/2024 20:46:29

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of ...

armata-pharmaceuticals-has-received-additional-525m-of-non-dilutive-funding-pursuant-to-previously-announced-department-of-defense-grant-to-support-development-of-its-optimized-phage-candidate-ap-sa02-for-complicated-staphylococcus-aureus-bacteremia
Armata Pharmaceuticals Has Received Additi...
07/30/2024 11:16:01

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
07/11/2024 13:43:01

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-achieved-full-enrollment-in-its-tailwind-phase-2-study-of-inhaled-ap-pa02-in-patients-with-ncfb-and-chronic-pulmonary-pseudomonas-aeruginosa-infection-topline-data-is-expected-in-the-second-half-of-2024
Armata Pharmaceuticals Achieved Full Enrol...
07/11/2024 11:09:07

armata-pharmaceuticals-to-present-viruses-of-microbes-2024
Armata Pharmaceuticals To Present Viruses ...
07/10/2024 20:09:35

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
05/08/2024 13:35:03

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

armata-pharmaceuticals-q1-eps-069-misses-031-estimate-sales-96600k-miss-110m-estimate
Armata Pharmaceuticals Q1 EPS $(0.69) Miss...
05/07/2024 20:41:10

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate o...

hc-wainwright--co-maintains-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Maintains Buy on Armat...
03/22/2024 14:58:52

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 pr...

armata-pharmaceuticals-q4-eps-055-misses-035-estimate-sales-153m-beat-86000k-estimate
Armata Pharmaceuticals Q4 EPS $(0.55) Miss...
03/21/2024 20:07:48

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate o...

Core News & Articles
Armata Pharmaceuticals Enters Secured Cred...
03/04/2024 21:03:01

The gross proceeds to be received by the Company at closing are $35 million before deducting transaction-related expenses. Proc...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/10/2024 17:31:03

armata-pharmaceuticals-q3-eps-086-misses-031-estimate-sales-123m-beat-95000k-estimate
Armata Pharmaceuticals Q3 EPS $(0.86) Miss...
11/14/2023 21:05:24

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate o...

armata-pharmaceuticals-announces-presentation-of-topline-data-from-swarm-pa-clinical-study-of-ap-pa02-for-chronic-pulmonary-pseudomonas-aeruginosa-infections-in-cystic-fibrosis-patients-at-north-american-cystic-fibrosis-conference
Armata Pharmaceuticals Announces Presentat...
10/30/2023 12:07:59

armata-pharmaceuticals-has-dosed-the-first-patient-in-the-phase-2a-portion-disarm-study-of-ap-sa02for-staphylococcus-aureus-bacteremia
Armata Pharmaceuticals Has Dosed The First...
09/26/2023 12:13:47

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
08/22/2023 17:31:17

hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Arma...
08/14/2023 15:09:55

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/27/2023 17:31:04

why-universal-health-services-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Universal Health Services Shares Are T...
07/26/2023 17:57:17

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting C...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION